Cart
sales@molnova.com
Calenduloside E
CAS No. 26020-14-4
Calenduloside E( —— )
Catalog No. M18321 CAS No. 26020-14-4
Calenduloside E exhibits hypoglycemic activities by suppressing the transfer of glucose from the stomach to the small intestine and by inhibiting glucose transport at the brush border of the small intestine in oral glucose-loaded rats.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 275 | In Stock |
|
| 10MG | 392 | In Stock |
|
| 25MG | 654 | In Stock |
|
| 50MG | 910 | In Stock |
|
| 100MG | 1228 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCalenduloside E
-
NoteResearch use only, not for human use.
-
Brief DescriptionCalenduloside E exhibits hypoglycemic activities by suppressing the transfer of glucose from the stomach to the small intestine and by inhibiting glucose transport at the brush border of the small intestine in oral glucose-loaded rats.
-
DescriptionCalenduloside E exhibits hypoglycemic activities by suppressing the transfer of glucose from the stomach to the small intestine and by inhibiting glucose transport at the brush border of the small intestine in oral glucose-loaded rats.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayEndocrinology/Hormones
-
TargetOpioid Receptor
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number26020-14-4
-
Formula Weight632.83
-
Molecular FormulaC36H56O9
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (158.02 mM)
-
SMILESCC1(CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(C5(C)C)OC6C(C(C(C(O6)C(=O)O)O)O)O)C)C)C2C1)C)C(=O)O)C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Matsuda, H., et al.: Chem. Pharma. Bull., 46, 1399 (1998); Matsuda, H., et al.: Biol. Pharma. Bull., 20, 717 (1997)
molnova catalog
related products
-
PF-04455242 hydrochl...
PF-04455242 is a potent, selective κ-opioid receptor (KOR) antagonist with Ki of 3 nM/21 nM/22 nM for hKOR/rKOR/mKOR, respectively.
-
IPAG
IPAG is a potent σ-receptor antagonist (pKi=4.3). IPAG can induce cell apoptosis.
-
CTAP
Potent and selective μ opioid receptor antagonist (IC50 = 3.5 nM). Displays > 1200-fold selectivity over δ opioid and somatostatin receptors. Brain penetrant and active in vivo.
